July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the broader market is once again near all-time highs, a testament to the ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...

Eli Lilly is grabbing investor attention thanks to sharp earnings and revenue growth projections, though its Zacks Rank ...

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides ...

In 2024, Eli Lilly partnered with Amazon (NASDAQ:AMZN) to offer home delivery of select medications. 2. Johnson & Johnson Market cap: $373.90 billion (as of June 3) Revenue (TTM): $89.3 billion ...

The healthcare sector, represented by the Health Care Select Sector SPDR Fund (NYSEARCA:XLV), underperformed the broader ...

Eaton Vance Tax-Managed Diversified Equity Income Fund, a CEF, provides investors with a diversified equity income strategy.

DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs, market share of individual therapies, and current ...

Achmea Investment Management B.V. increased its Pfizer stake by a whopping 194.2% in Q1, reaching over 311,000 shares valued ...